FDA reacts to possible link between autism and paracetamoli

The American Food and Bars Agency (FDA) has launched this Tuesday the process of changing the use of acetaminophen (products like Tylenol or precetamol as it is known in Europe), supporting indicators that using this drug from pregnant women can be linked to an increased risk of developing neurologic disorders, such as [...]
In addition, the agency has sent a warning letter to doctors throughout the United States.
“The FDA is taking steps to inform parents and doctors of a considerable amount of evidence of possible risks associated with the acetaminopheen,” said FDA commissioner Marty Makary, M.D., M.P.H.
Although there is this evidence, the final decision belongs to parents. A careful principle can lead many to avoid using acetaminophen during pregnancy, especially since most light fever does not require treatment. However, it is reasonable for pregnant women to use acetaminophen in certain situations”- the FDA reported.
In recent years, several major studies, including Nurssé Health Study II and Boston Byth Cohort, have found a link between the use of acetaminophen during pregnancy and the recent diagnosis of diseases such as autism and ADD. Some of these studies mention that the risk is higher when medication is used chronically throughout pregnancy.
It is important to note, however, that while a link between acetaminophen and neurologic disorders in some studies has not been confirmed, studies that do not support this relationship are also found in scientific literature. And acetaminophen is the only nonprescriptionic drug that has been adopted for treating fevers during pregnancy, which can be dangerous for the fetus. Moreover, aspirin and ibuprofen have negative effects on the fetus.












